Teva Pharmaceuticals found liable in New York opioid trial - BBC News
Teva takes 2nd long-acting schizophrenia drug into phase 3
TEVA Stock Alert: What to Know About Teva Pharmaceuticals' New CEO | InvestorPlace
Teva Posts 2021 Earnings and Puts Opioid Litigation in Rearview Mirror | BioSpace
Teva Pharmaceutical: Slow Road To A Higher Share Price (NYSE:TEVA) | Seeking Alpha
Teva Pharmaceuticals: Israeli drugmaker to cut 14,000 jobs - BBC News
Teva reaches proposed $4.35 billion settlement of US opioid lawsuits | CNN Business
Teva Pharmaceutical meets forecasts, but 2023 outlook disappoints | Reuters
Teva slide could draw vultures but it won't be easy prey | The Times of Israel
Teva Pharmaceuticals will pay $420 million in a federal case
Teva Pharmaceuticals (@TevaUSA) / Twitter
Teva Pharmaceuticals agrees to pay $523M to settle opioid crisis claims - UPI.com
Teva Pharmaceuticals | Israel National News - Arutz Sheva
Teva Factory Shutdown in Irvine Affects 25 Drugs: Report - Orange County Business Journal
Opioid Lawsuit Against Teva Pharma
Pharmaceutical Company Reaches Settlement With Oklahoma In Opioid Case : NPR
Teva enters opioid settlement agreement with US state Rhode Island
Teva Pharmaceuticals Q4 2016 Earnings
Teva Stock: Teva Guides To Its First Year Of Growth Since 2017, But There's A Caveat | Investor's Business Daily
Teva Pharmaceuticals USA - News, Articles etc. - European Pharmaceutical Review
Israel's Teva Pharm to start paying US opioid settlement in 2023 -CEO - The Jerusalem Post
Teva Pharmaceuticals to pay New York $523 million to settle claims from its role in opioids crisis - ABC News
Teva Pharmaceuticals, NY reach opioid lawsuit settlements worth $523M - Top Class Actions
Teva Pharmaceuticals - Wikipedia
The Teva-Allergan deal shows why pharma mergers are booming | Fortune
